• Search
  • Helpdesk
  • Sales contact
Get your demo
☰

Article

Rare disease clinical research: it is time to tackle what matters most to patients

Rare disease
Supporting the development and evaluation of new treatments for rare diseases has become a key priority of the 21st century. Over 7,000 distinct rare diseases, affecting around 36 million people...

The importance of ePRO to support NASH/NAFLD unmet clinical research and medical needs

MetabolicScientific advice
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally and is the most severe...

The relevance of ePROs in early phase clinical trials

Scientific advice
Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the investigational product in humans, finding...

3 considerations to take into account when setting up an eCOA clinical trial

Televisit
In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic...

Kayentis 2023 Gender Equality Index

CSR
In accordance with the provisions of the French "Professional Future" law of September 5, 2018, Kayentis has established its Gender...

Implementing electronic Patient Reported Outcomes (ePROs) in Arthritis Clinical Research: Importance, benefits, and management for incorporating ePROs

Immuno-Inflammation
Arthritis is a general term categorized by acute or chronic inflammation of the joints. Arthritis may cause a variety of...

Direct insights from cancer patients: How they help us understand disease burden and the need for an individualized approach

OncologyPatients insights
Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt to...

The shift to data collection at home: Strategies to support flexibility, ensure data quality, and preserve data privacy

Scientific advice
The rate at which we now collect data in clinical trials is astonishing. With decentralization of clinical trials, study data...

Kayentis Media Player, for informed and engaged patients in clinical trials

Patient engagement
Patients taking part in clinical trials need clear and simple information – this is what 70% of 1,133 survey participants...

Giving voice to study patients via the Participant Feedback Questionnaire

Patient engagement
Increasing the engagement of study patients can be done in multiple ways: one way to do it is to ask...
,

Decentralized Clinical Trials
Essential tips to avoid common pitfalls

Scientific advice
Despite the numerous advantages of Decentralized Clinical Trials, reducing on-site visit means that data endpoints need to be captured via...

Mitigating the risks of long-term oncology eCOA clinical trials

Oncology
Long study duration can have a negative impact on patient compliance As for any clinical trial, poor compliance in oncology...

Televisits in clinical trials: Why integrate a telemedecine feature in your eCOA trials?

Televisit
With clinical trials digitalization and decentralization comes the possibility for patients to complete several of their clinical study procedures remotely,...

Addressing the specific complexities of oncology eCOA clinical trials

Oncology
The oncology research pathway is paved with numerous challenges, and oncology clinical trials have one of the lowest success rates....

DCT trials

The added value of a single platform DCT trials means bringing the study to the patient’s environment instead of asking...

Expanding flexibility of eCOA data collection with controlled interview mode

Patient engagement
With quickly evolving technologies, electronic Patient Reported Outcomes (ePROs) can now be administered in a variety of ways. If ePRO...

Key considerations for the implementation of successful Decentralized Clinical Trials (DCTs)

Many chronic diseases such as invasive cancers, inflammatory disorders, cardiovascular, or central nervous system diseases can have a significant impact...

3 good reasons to adopt Decentralized Clinical Trials (DCT)

The clinical trials industry has been facing numerous and long-lasting challenges of patient recruitment and retention, patient compliance, and clinical...

Paving the way towards carbon neutral eCOA trials

CSR
COVID-19 caused businesses to adopt new practices, including moving many operations online and leading to a positive impact on CO2...

Clinical trials digitalization: why it helps clinical trials stakeholders

The decline in R&D efficiency is one of the biggest challenges the pharmaceutical industry is facing today. The development of...
Default Image

How can digital innovation turn clinical trials into a positive patient and site experience?

Digital innovation is increasingly penetrating the healthcare industry and technological advances create a new avenue for the optimization of clinical...

Data Management – Essential for all studies including eCOA

Data management
  In a perfect world, you would choose your Clinical Outcome Assessments (COAs), write your statistical analysis plan (SAP), license...

WebCOA back-up
The best balance for data quality, ease-of-use, and cost for your clinical studies!

webcoa
7 reasons to choose a web-based back-up solution for your eCOA studies   WebCOA is a back-up solution, which is...

eCOA solutions in oncology: how to avoid common pitfalls and ensure the success of long-term studies?

Oncology
Among numerous clinical study procedures, capturing patients reported outcomes can bring its own set of challenges and, if not well...

Partnering with patients to boost clinical research in rare diseases

Patients insightsRare disease
Although much progress has been made in developing scientific knowledge and conducting clinical research in rare diseases, serious challenges remain....

eCOA Training: how can we improve the sites’ and patients’ experience? #whitepaper

Patient engagementProject management
Focused on eCOA training, this white paper transcribes the discussion from one in a series of 4 workshops about eCOA...

Overcoming the Complexities of Pediatric Clinical Trials

Pediatric
Although children make up 25% of the world’s population, at least 50% of all drug products may still lack labeling...

Waste Management Report 2018

CSR
Kayentis is committed to responsible waste management After the promotion of environmentally friendly transport - 2018 Sustainable Mobility Report - (e.g....
Follow us on social media
Subscribe to our newsletter
You may also like

Rare disease clinical research: it is time to tackle what...

Biotech and eCOA vendor: A shared mindset

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

About the author
Picture of Céline Hollinger

Céline Hollinger

Celine brings almost two decades of communications experience in the life sciences. As a co-founder of a healthcare communication agency for over a decade, she has supported top pharma and innovative healthcare companies. Since April 2019, she has been leading marketing and communication at Kayentis with her innovative strategies.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA